The Pharma Legal Handbook: Switzerland

Switzerland is one of the world's most important pharmaceutical markets and home to some of its largest companies, including Novartis and Roche. Operating here requires a thorough understanding of a regulatory framework that combines Swissmedic oversight, unique Swiss pricing and reimbursement structures, and a set of marketing and clinical trial rules that differ in important respects from the EU system.

The Pharma Legal Handbook: Switzerland provides authoritative, country-specific answers to the regulatory and legal questions that matter most to companies operating in or entering the Swiss market. Developed in association with Wenger Plattner, a leading Swiss law firm with deep expertise in life sciences and healthcare regulation, it covers the full regulatory lifecycle from product licensing and clinical trials through to pricing, reimbursement, pharmacovigilance, manufacturing, trademarks, and patents.

Whether you are preparing a market entry strategy, managing an existing product portfolio in Switzerland, or advising clients on Swiss pharmaceutical law, this handbook gives you the foundational regulatory knowledge you need in a single, structured reference.

If legal handbook content is updated, you will receive a free updated PDF for up to one year after purchase. 

Updated October 2022